MEDIMI AB |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0278 SEK | -5.44% |
|
-6.71% | -15.76% |
| 05-14 | Medimi AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 02-13 | Medimi AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
| Sales 2022 | 2.07M 198K 271K | Sales 2023 | 3.63M 347K 476K | Capitalization | 34.35M 3.29M 4.51M |
|---|---|---|---|---|---|
| Net income 2022 | -15M -1.44M -1.97M | Net income 2023 | -14M -1.34M -1.84M | EV / Sales 2022 | 14.1 x |
| Net cash position 2022 | 10.65M 1.02M 1.4M | Net cash position 2023 | 9.31M 892K 1.22M | EV / Sales 2023 | 6.9 x |
| P/E ratio 2022 |
-2.58
x | P/E ratio 2023 |
-2.41
x | Employees | 6 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 35.05% |
More Fundamentals
* Assessed data
More news
| 1 day | -5.44% | ||
| 1 week | -6.71% | ||
| Current month | +33.65% | ||
| 1 month | +47.87% | ||
| 3 months | +33.65% | ||
| 6 months | -22.78% | ||
| Current year | -15.76% |
1 week
0.02
0.03
1 month
0.020.04
Current year
0.010.04
1 year
0.010.08
3 years
0.010.53
5 years
0.010.98
10 years
0.012.48
| Managers | Title | Age | Since |
|---|---|---|---|
Håkan Harvigsson
COO | Chief Operating Officer | 61 | 16-01-31 |
Johnny Andersen
IRO | Public Communications Contact | 60 | 17-06-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 71 | 18-03-28 | |
Ulf Lindahl
BRD | Director/Board Member | 67 | 18-12-31 |
| Director/Board Member | 56 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-18 | 0.0278 | -5.44% | 1,765,389 |
| 24-06-17 | 0.0294 | +10.53% | 2,826,698 |
| 24-06-14 | 0.0266 | -13.64% | 2,875,190 |
| 24-06-13 | 0.0308 | +9.22% | 2,688,449 |
| 24-06-12 | 0.0282 | -5.37% | 2,006,519 |
End-of-day quote NORDIC GROWTH MARKET, June 17, 2024
More quotes
Medimi AB, formerly MedicPen Aktiebolag (publ) is a Sweden-based company operating within healthcare and pharmaceutical industries. Medimi develops solutions that provide healthcare recipients and staff with drug management. The business focus is to develop, manufacture and sell products that facilitate patient medication. The products are sold under separate brands and include systems for medication assistance that send alarms at missed doses to relatives or caregivers, and the Company manufactures stationary tablet dispensers. The solution covers the entire chain, from doctors to dispensing at home. The products are at the forefront of technology and are developed for integration into IT environments.
Calendar
2024-07-31
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -15.76% | 2.87M | |
| +75.69% | 12.57B | |
| +15.86% | 7.21B | |
| -30.02% | 6.82B | |
| +12.09% | 5.35B | |
| +10.93% | 3.99B | |
| -25.26% | 3.77B | |
| -30.02% | 2.64B | |
| +30.21% | 2.09B | |
| -1.24% | 2.04B |
- Stock Market
- Equities
- MEDIMI Stock
